• Search
  • Helpdesk
  • Sales contact
Get your demo

Kayentis solution

Kayentis and Ametris join forces to deliver integrated eCOA solution measuring and improving wearable technology adherence in clinical trials

More than simply unifying wearable and patient-reported data in one app, integrated solution directly tackles major challenge in wearable enabled clinical trials: wearable device adherence. By embedding real time compliance...

Engage patients throughout the clinical trial journey

Patient engagement
Want to engage patients throughout the clinical trial journey? Boost retention and drive compliance with patient engagement modules seamlessly integrated...

Kayentis introduces its Patient Education Video Library to strengthen clinical trial engagement and compliance

Patient engagement
Co-created with patient advocates and integrated into the Kayentis electronic Clinical Outcome Assessment (eCOA) application, patient educational videos enrich Kayentis’...

Biotech and eCOA vendor: A shared mindset

Project management
Biotechs play a pivotal role in driving innovation, contributing significantly to the development of groundbreaking therapies for patients. But they...

Kayentis operational excellence

Project management
Why do customers recommend Kayentis for operational excellence? More than 95% of Kayentis customers recommend Kayentis for its:Customer-centric approachEnd-to-end project...

Why you should implement a BYOD strategy for your eCOA trial

BYOD
Improve your clinical trial efficiency and offer more choice to patients by implementing a BYOD strategy for your eCOA trial!...

How Kayentis Helps You Manage The Growing Complexities Of eCOA Trials

Project management
We all know clinical trials are more and more complex, involving an increasing number of systems, multiple populations, and an...

Emerging Biopharma & Biotech (EBP) – 5 key success factors for your clinical trials

biotech
With so much at stake, consider partnering with an eCOA and DCT expert!Kayentis offers a unified platform featuring trustworthy services...

How is the Kayentis Clin’form solution perceived by site staff users? 

Sites perspectives
The survey, conducted in November 2022, involved 239 site respondents from Europe (47%), Americas (27%), Asia (20%), and the Middle...

Kayentis raises further €5M to boost US activities

Additional funds will be used to scale-up Kayentis’ operations in North America to support clinical trials Grenoble, France, March 28,...

Clin’form App: The Kayentis BYOD solution

BYODPatient engagement
Clin’form App is the Kayentis BYOD solution, available for patients and caregivers to facilitate decentralized and hybrid trials, and improve...

Kayentis Media Player, for informed and engaged patients in clinical trials

Patient engagement
Patients taking part in clinical trials need clear and simple information – this is what 70% of 1,133 survey participants...

Kayentis BYOD solution: Ensuring adoption by sites and patients

BYOD
What if a patient breaks or loses their smartphone during the study? What if they fear using the Clin’form App...

Participant Feedback Questionnaire, a voice for study patients!

Patient engagement
The need to engage patients during clinical trials is no longer debatable; the question is how clinical trial stakeholders can...

Giving voice to study patients via the Participant Feedback Questionnaire

Patient engagement
Increasing the engagement of study patients can be done in multiple ways: one way to do it is to ask...

Televisits for more engaging clinical trials

Televisit
If it is important to enable televisits for DCT trials, embedding the feature directly into the eCOA app brings multiple...

Engage clinical trial participants throughout a trial
with our easy-to-use media player embedded in our eCOA app

Patient engagement
Provide clinical trial participants with clear and simple information, anywhere, anytime thanks to the Kayentis Media Player. Download the Kayentis...

Customizing eCOA questionnaire design to improve the pediatric experience

Pediatric
Dedicated to improve patient experience in clinical trials, Kayentis’ Clin’form solution offers the flexibility to customize questionnaire design with illustrations...

Decentralized Clinical Trials
Using Kayentis’ unified platform for an enhanced patient experience

Patient engagement
Improving patients’ experience using Kayentis unified platform and implementing robust technology integration.Visiting sites remotelyReceiving study information and supportProviding study experience...
Default Image

Kayentis launches fully integrated platform for decentralized clinical trials

Grenoble, France, March 23, 2022 - Kayentis, a global provider of eCOA and Decentralized Clinical Trial solutions, today announces the...

Interview mode: a valuable data collection alternative supporting Decentralized Clinical Trials

Patient engagement
Collecting ePRO & eObsRO data via interview mode can be recommended in specific circumstances, according to the medical conditions, operational...

Choose a strong partner to ensure the success of your decentralized clinical trials!
6 good reasons to select Kayentis

Choose a strong partner to ensure the success of your decentralized clinical trials! Download the infographic Get your demo

Clinical trials digitalization: why it helps clinical trials stakeholders

The decline in R&D efficiency is one of the biggest challenges the pharmaceutical industry is facing today. The development of...
Default Image

How can digital innovation turn clinical trials into a positive patient and site experience?

Digital innovation is increasingly penetrating the healthcare industry and technological advances create a new avenue for the optimization of clinical...
Default Image

Let’s listen to what patients have to tell us!

Patients insights
Because of the pandemic, have you felt... …anxious for your/your family’s health? …worried for your job? …isolated or lonely during...

Plan a successful web back-up strategy for your clinical trials

webcoa
Have you anticipated all situations? Discover the key advantages of our WebCOA back-up! Guarantee patient & site compliance Site staff...

Partnering with patients to boost clinical research in rare diseases

Patients insightsRare disease
Although much progress has been made in developing scientific knowledge and conducting clinical research in rare diseases, serious challenges remain....
Default Image

Press Release // Kayentis raises €7M ($8.3M) to accelerate the global expansion of its digital platform for clinical trials

Funds will strengthen Kayentis’ digitalization approach in transforming how pharma, investigator sites and patients engage in clinical trials Grenoble, France,...

Make it simple: Use a single device! #infography

Discover the 3 key advantages of using a single device for both on-site and home use: #1 Simplicity for sites#2...

REGISTER FOR OUR VIRTUAL PRESENTATION – Nov 3, Clinical Trials Europe

eCOA SETUP: HOW TO ENSURE A SUCCESSFUL LAUNCH BY NAVIGATING COMPLEXITIES Prepare Specifications: how to mitigate risk and anticipate complexities...

eCOA Training: how can we improve the sites’ and patients’ experience? #whitepaper

Patient engagementProject management
Focused on eCOA training, this white paper transcribes the discussion from one in a series of 4 workshops about eCOA...

Make clinical trials an enjoyable experience: use a small tablet device! #infography

A small tablet is the perfect choice between a smartphone and a "classic" tablet. A user-friendly device, it is adapted...

ePRO and eDiary: What about using a single device?

With the increasing importance of direct patient input into clinical trials, most protocols combine ePRO and eDiary questionnaires for use...

Press Release // Kayentis forges ahead on five new eCOA service projects with emerging biopharma firms in Europe and US

Kayentis sets up incoming EBPs, major contributors in biomedical innovation, as well as its existing clients, with contingency plans to...

Press Release // Kayentis opens Japanese subsidiary to support growth of Asia-Pacific clinical trials sector

Proximity will facilitate local and international sponsor access to Kayentis’ eCOA services for mid- to later-stage clinical trials Kayentis will...

Kayentis extends its contribution to scientific research in clinical trial endpoint assessment and joins the Critical Path Institute’s ePRO Consortium

eCOA consortium
Kayentis announces that it has joined the C-Path's ePRO Consortium, a nonprofit organization dedicated to advance the science of clinical...
Default Image

Press Release // Kayentis appoints Estelle Haenel as medical director

Scientific advice
25-year pharma industry veteran and clinical trials expert will strengthen Kayentis’ eCOA offering to sponsors seeking to use digital patient-facing...

Kayentis welcomes Estelle Haenel, PharmD, PhD, as Medical Director

Scientific advice
Estelle Haenel has joined Kayentis as Medical Director. She will help leverage the company’s growing medical expertise bringing to Kayentis...

Press release // OMRON Healthcare and Kayentis join forces to deliver an integrated and cost-efficient approach to remote monitoring of patients in clinical trials

We are proud to announce our collaborative work with OMRON Healthcare on the development of an integrated and cost-efficient approach...

Kayentis releases its 2018 customer satisfaction survey: The results are in!

Project management
Customer satisfaction survey 2018: The results are in! Rapid growth and diversification of clients brought new challenges this year, so...

Kayentis Partners with OmniComm to Offer Integrated EDC and eCOA Solutions

        Fort Lauderdale, FL - OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data...

Kayentis announces the release of its new eCOA solution, Clin’form3 Suite

A multi-platform eCOA solution to address the clinical trial needs of the future Over the last 2 years, Kayentis has...

// Innovation by Kayentis // R&D moves into an ‘Agile’ mode of operation

How the Agile mode, implemented in Kayentis’ R&D department, improves the quality of solutions as well as client satisfaction. It’s...

Kayentis announces a breakthrough feature available in ePRO clinical trials: clinician review of data on a tablet device

It is essential that clinicians review PRO data. When patients complete questionnaires using a tablet, the use of different device...
Default Image

Kayentis goes one step further in the integration of electronic Informed Consent to improve patient convenience and sponsor efficiency

The announcement in May 2016 of the partnership between Kayentis and SecureConsent was just the first step in the integration...

Kayentis releases its 2016 customer satisfaction survey

Project management
Kayentis proud to publish the results of its customer satisfaction survey Conducted among more than 60 Kayentis clients, this investigation reveals that 90% of surveyed...

Kayentis closes 3.6 M€ growth financing round

Innovation Capital and Extens finance 3.6 M€ round to accelerate the international growth of Kayentis. Kayentis, a global provider of electronic...

KAYENTIS announces its participation in the Avoca Diligent Prequalification Platform

Choosing a provider in the clinical trials market is a costly and time-consuming process for sponsors and CROs. To better...

A step further in improving clinical trials: an electronic informed consent fully integrated into the eCOA solution

KAYENTIS signs a partnership with eNFORME to combine SecureConsent® eICF solution with Kayentis eCOA’s platform. From now on, Kayentis provides...

Kayentis signs up 5 new phase III clinical studies

These phase III clinical studies, supported by Top10 pharma laboratories, will be using the tablet-based data capture solution developed by...

Kayentis announces the creation of its strategic committee

Four leading figures in Life Sciences have accepted director Guillaume Juge’s invitation to join the body and they are Pr...

Kayentis finalized its round of funding in february

Kayentis finalized in February 2015 a round of funding with the arrival of Extens, a fund dedicated to e-health, alongside...
Follow us on social media
Subscribe to our newsletter
You may also like

Kayentis and Ametris join forces to deliver integrated eCOA solution...

Navigating BYOD in Clinical Research: Insights for Clinical Trial Success

ePRO in early phase oncology trials: A revolution on the...

Patient-Reported Outcomes in early-phase oncology clinical trialsA Stepping Stone to...

Answering the Sustainability Call: Digital Health Technologies and eCOA

Kayentis secures Silver Medal in EcoVadis sustainability evaluation with significant...

About the author
Picture of Marc Chaperon

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.